Personalized Glaucoma Coaching for Glaucoma
(SEE Trial)

Recruiting in Palo Alto (17 mi)

+1 other location

Overseen byPaula Newman-Casey, MD MS

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Waitlist Available

Sponsor: University of Michigan

No Placebo Group

Trial Summary

What is the purpose of this trial?This study will test whether the Support, Educate, Empower (SEE) personalized Glaucoma Coaching Program improves eye drop medication adherence among glaucoma patients compared to enhanced standard care in a randomized controlled clinical trial. As a secondary outcome, the study will test whether glaucoma related distress decreases among SEE program participants compared to the control group. The study hypothesis is that glaucoma patients with poor adherence who receive motivational-interviewing based counseling and personalized education from a trained non-physician glaucoma coach through the SEE Program will improve their medication adherence compared to glaucoma patients standard care enhanced by additional educational handouts.

Eligibility Criteria

This trial is for English-speaking glaucoma patients who are currently using eye drop medication and have not had recent or planned glaucoma surgery. It's not suitable for those with cognitive impairments, serious mental illnesses like schizophrenia, active eye infections, uveitis, or who can't manage their own eye drops.

Inclusion Criteria

Taking greater or equal to 1 ocular hypotensive medication with a diagnosis of any kind of glaucoma, suspected glaucoma or ocular hypertension

Did not opt-out from recruitment letter

Exclusion Criteria

Do not speak English

Had laser or incisional glaucoma surgery within three months of enrollment or scheduled during the six-month study period

Do not instill their own eye drops

+4 more

Participant Groups

The SEE Program offers personalized coaching to help improve how well patients stick to their glaucoma medication routine compared to just getting extra educational materials. The program includes motivational talks and education from a non-doctor coach.

2Treatment groups

Experimental Treatment

Active Control

Group I: Personalized Glaucoma CoachingExperimental Treatment1 Intervention

This is a six-month personalized glaucoma coaching program where a coach trained in motivational interviewing (MI)-based counseling uses a web-based tool that generates tailored education to help glaucoma patients identify their barriers to optimal medication adherence and explore potential solutions during three in-person coaching sessions. The coach provides between-session support through four phone calls, with two phone calls between the first and second sessions and one call after each subsequent session. Participants can elect to receive any of the following types of alarm when a dose of medication is due: visual or audible alert or automated text or phone call reminder. Glaucoma medication adherence will be monitored electronically for all participants between the baseline visit and the exit visit six months later.

Group II: Enhanced standard careActive Control1 Intervention

Participants will receive non-tailored educational materials about glaucoma from leading sources by mail every 2 months for a total of 3 mailings during the 6-month study period. Glaucoma medication adherence will be monitored electronically for all participants between the baseline visit and the exit visit six months later.